T0	Interventions 23 39	oral conivaptan:
T1	Interventions 42 80	V1A/V2 vasopressin receptor antagonist
T2	Interventions 108 126	placebo-controlled
T3	Interventions 508 569	oral conivaptan, a vasopressin V(1A)/V(2) receptor antagonist
T4	Interventions 662 680	placebo-controlled
T5	Interventions 774 789	Oral conivaptan
T6	Interventions 809 816	placebo
T7	Interventions 1163 1173	conivaptan
T8	Interventions 1278 1286	placebo.
T9	Interventions 1404 1411	placebo
T10	Interventions 1432 1442	conivaptan
T11	Interventions 1479 1489	conivaptan
T12	Interventions 1768 1775	placebo
T13	Interventions 1803 1813	conivaptan
T14	Interventions 1845 1855	conivaptan
T15	Interventions 1994 2001	placebo
T16	Interventions 2021 2031	conivaptan
T17	Interventions 2055 2065	conivaptan
T18	Interventions 2197 2212	Oral conivaptan